Barton ER - Search Results

1

Functional improvement of dystrophic muscle by myostatin blockade.

Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS. Bogdanovich S, et al. Among authors: barton er. Nature. 2002 Nov 28;420(6914):418-21. doi: 10.1038/nature01154. Nature. 2002. PMID: 12459784

2

Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice.

Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL. Barton ER, et al. J Cell Biol. 2002 Apr 1;157(1):137-48. doi: 10.1083/jcb.200108071. Epub 2002 Apr 1. J Cell Biol. 2002. PMID: 11927606 Free PMC article.

3

Correction of the dystrophic phenotype by in vivo targeting of muscle progenitor cells.

Kobinger GP, Louboutin JP, Barton ER, Sweeney HL, Wilson JM. Kobinger GP, et al. Among authors: barton er. Hum Gene Ther. 2003 Oct 10;14(15):1441-9. doi: 10.1089/104303403769211655. Hum Gene Ther. 2003. PMID: 14577924

4

Systemic administration of L-arginine benefits mdx skeletal muscle function.

Barton ER, Morris L, Kawana M, Bish LT, Toursel T. Barton ER, et al. Muscle Nerve. 2005 Dec;32(6):751-60. doi: 10.1002/mus.20425. Muscle Nerve. 2005. PMID: 16116642

5

Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy.

Millay DP, Sargent MA, Osinska H, Baines CP, Barton ER, Vuagniaux G, Sweeney HL, Robbins J, Molkentin JD. Millay DP, et al. Among authors: barton er. Nat Med. 2008 Apr;14(4):442-7. doi: 10.1038/nm1736. Epub 2008 Mar 16. Nat Med. 2008. PMID: 18345011 Free PMC article.

6

Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice.

Morine KJ, Bish LT, Pendrak K, Sleeper MM, Barton ER, Sweeney HL. Morine KJ, et al. Among authors: barton er. PLoS One. 2010 Feb 11;5(2):e9176. doi: 10.1371/journal.pone.0009176. PLoS One. 2010. PMID: 20161803 Free PMC article.

7

Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy.

Morine KJ, Bish LT, Selsby JT, Gazzara JA, Pendrak K, Sleeper MM, Barton ER, Lee SJ, Sweeney HL. Morine KJ, et al. Among authors: barton er. Muscle Nerve. 2010 Nov;42(5):722-30. doi: 10.1002/mus.21743. Muscle Nerve. 2010. PMID: 20730876 Free PMC article.

8

Leupeptin-based inhibitors do not improve the mdx phenotype.

Selsby J, Pendrak K, Zadel M, Tian Z, Pham J, Carver T, Acosta P, Barton E, Sweeney HL. Selsby J, et al. Am J Physiol Regul Integr Comp Physiol. 2010 Nov;299(5):R1192-201. doi: 10.1152/ajpregu.00586.2009. Epub 2010 Sep 15. Am J Physiol Regul Integr Comp Physiol. 2010. PMID: 20844259 Free PMC article.

9

Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice.

Bish LT, Yarchoan M, Sleeper MM, Gazzara JA, Morine KJ, Acosta P, Barton ER, Sweeney HL. Bish LT, et al. Among authors: barton er. PLoS One. 2011;6(6):e20856. doi: 10.1371/journal.pone.0020856. Epub 2011 Jun 22. PLoS One. 2011. PMID: 21731628 Free PMC article.

10

Rescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouse.

Selsby JT, Morine KJ, Pendrak K, Barton ER, Sweeney HL. Selsby JT, et al. Among authors: barton er. PLoS One. 2012;7(1):e30063. doi: 10.1371/journal.pone.0030063. Epub 2012 Jan 11. PLoS One. 2012. PMID: 22253880 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters